Hepsin-mediated Processing of Uromodulin is Crucial for Salt-sensitivity and Thick Ascending Limb Homeostasis
Authors
Affiliations
Uromodulin is a zona pellucida-type protein essentially produced in the thick ascending limb (TAL) of the mammalian kidney. It is the most abundant protein in normal urine. Defective uromodulin processing is associated with various kidney disorders. The luminal release and subsequent polymerization of uromodulin depend on its cleavage mediated by the serine protease hepsin. The biological relevance of a proper cleavage of uromodulin remains unknown. Here we combined in vivo testing on hepsin-deficient mice, ex vivo analyses on isolated tubules and in vitro studies on TAL cells to demonstrate that hepsin influence on uromodulin processing is an important modulator of salt transport via the sodium cotransporter NKCC2 in the TAL. At baseline, hepsin-deficient mice accumulate uromodulin, along with hyperactivated NKCC2, resulting in a positive sodium balance and a better adaptation to water deprivation. In conditions of high salt intake, defective uromodulin processing predisposes hepsin-deficient mice to a salt-wasting phenotype, with a decreased salt sensitivity. These modifications are associated with intracellular accumulation of uromodulin, endoplasmic reticulum-stress and signs of tubular damage. These studies expand the physiological role of hepsin and uromodulin and highlight the importance of hepsin-mediated processing of uromodulin for kidney tubule homeostasis and salt sensitivity.
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.
Bazua-Valenti S, Brown M, Zavras J, Riedl Khursigara M, Grinkevich E, Sidhom E J Clin Invest. 2024; 134(24).
PMID: 39680459 PMC: 11645142. DOI: 10.1172/JCI180347.
Advances in uromodulin biology and potential clinical applications.
Nanamatsu A, de Araujo L, LaFavers K, El-Achkar T Nat Rev Nephrol. 2024; 20(12):806-821.
PMID: 39160319 PMC: 11568936. DOI: 10.1038/s41581-024-00881-7.
Yamamoto M, Takata T, Hanada H, Taniguchi S, Hamada S, Mae Y Clin Exp Nephrol. 2024; 28(8):728-739.
PMID: 38581621 DOI: 10.1007/s10157-024-02478-7.
Karagiannidis A, Theodorakopoulou M, Pella E, Sarafidis P, Ortiz A Nephrol Dial Transplant. 2024; 39(7):1073-1087.
PMID: 38211973 PMC: 11210992. DOI: 10.1093/ndt/gfae008.
Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.
Schiano G, Lake J, Mariniello M, Schaeffer C, Harvent M, Rampoldi L EMBO Mol Med. 2023; 15(12):e18242.
PMID: 37885358 PMC: 10701617. DOI: 10.15252/emmm.202318242.